BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38787429)

  • 61. Establishment and Validation of a Preoperative MRI-based Nomogram for Predicting the Risk of Malignancy in Patients with Breast Tumor.
    Lai J; Lin J; Wang H; Sun Y; Li Y; Tian H; Shen S; Tan C; Liu H; Yu F
    J Cancer; 2021; 12(3):799-806. PubMed ID: 33403037
    [No Abstract]   [Full Text] [Related]  

  • 62. Exploring the added value of pretherapeutic MR descriptors in predicting breast cancer pathologic complete response to neoadjuvant chemotherapy.
    Malhaire C; Selhane F; Saint-Martin MJ; Cockenpot V; Akl P; Laas E; Bellesoeur A; Ala Eddine C; Bereby-Kahane M; Manceau J; Sebbag-Sfez D; Pierga JY; Reyal F; Vincent-Salomon A; Brisse H; Frouin F
    Eur Radiol; 2023 Nov; 33(11):8142-8154. PubMed ID: 37318605
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study.
    Qian B; Yang J; Zhou J; Hu L; Zhang S; Ren M; Qu X
    Front Endocrinol (Lausanne); 2022; 13():955250. PubMed ID: 36060977
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic risk factors and survival models for T3 locally advanced rectal cancer: what can we learn from the baseline MRI?
    Zhao Q; Wan L; Zou S; Zhang C; E T; Yang Y; Ye F; Zhao X; Ouyang H; Zhang H
    Eur Radiol; 2021 Jul; 31(7):4739-4750. PubMed ID: 34003351
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Based on Intratumoral and Peritumoral DCE-MRI Radiomics Nomogram.
    Liu Y; Li X; Zhu L; Zhao Z; Wang T; Zhang X; Cai B; Li L; Ma M; Ma X; Ming J
    Contrast Media Mol Imaging; 2022; 2022():6729473. PubMed ID: 36051932
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer.
    Li Y; Chen Y; Zhao R; Ji Y; Li J; Zhang Y; Lu H
    Eur Radiol; 2022 Mar; 32(3):1676-1687. PubMed ID: 34767068
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An MRI-based Scoring System for Preoperative Prediction of Axillary Response to Neoadjuvant Chemotherapy in Node-Positive Breast Cancer: A Multicenter Retrospective Study.
    Huang X; Shi Z; Mai J; Liu C; Liu C; Chen S; Lu H; Li Y; He B; Li J; Cun H; Han C; Chen X; Liang C; Liu Z
    Acad Radiol; 2023 Jul; 30(7):1257-1269. PubMed ID: 36280517
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preoperative MRI and immunohistochemical examination for the prediction of high-risk endometrial cancer.
    Chen J; Fan W; Gu H; Zhang W; Liu Y; Wang Y; Pan Z; Wang Z
    Gland Surg; 2021 Jul; 10(7):2180-2191. PubMed ID: 34422589
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MR and mammographic imaging features of HER2-positive breast cancers according to hormone receptor status: a retrospective comparative study.
    Song SE; Bae MS; Chang JM; Cho N; Ryu HS; Moon WK
    Acta Radiol; 2017 Jul; 58(7):792-799. PubMed ID: 27754920
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Low breast density and peritumoral edema on MR predict worse overall survival of breast cancer patients after neoadjuvant chemotherapy.
    Yang Z; Wang N; Han R; Tang Y; Chen H; Xie Y; Wang R; Tang L
    Eur J Radiol; 2024 Feb; 171():111294. PubMed ID: 38218065
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preoperative prediction of axillary sentinel lymph node burden with multiparametric MRI-based radiomics nomogram in early-stage breast cancer.
    Zhang X; Yang Z; Cui W; Zheng C; Li H; Li Y; Lu L; Mao J; Zeng W; Yang X; Zheng J; Shen J
    Eur Radiol; 2021 Aug; 31(8):5924-5939. PubMed ID: 33569620
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk stratification of solitary hepatocellular carcinoma ≤ 5 cm without microvascular invasion: prognostic values of MR imaging features based on LI-RADS and clinical parameters.
    Wang L; Feng B; Li D; Liang M; Wang S; Wang S; Ma X; Zhao X
    Eur Radiol; 2023 May; 33(5):3592-3603. PubMed ID: 36884087
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enhancing recurrence risk prediction for bladder cancer using multi-sequence MRI radiomics.
    Yang G; Bai J; Hao M; Zhang L; Fan Z; Wang X
    Insights Imaging; 2024 Mar; 15(1):88. PubMed ID: 38526620
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Peritumoral Dilation Radiomics of Gadoxetate Disodium-Enhanced MRI Excellently Predicts Early Recurrence of Hepatocellular Carcinoma without Macrovascular Invasion After Hepatectomy.
    Chong H; Gong Y; Pan X; Liu A; Chen L; Yang C; Zeng M
    J Hepatocell Carcinoma; 2021; 8():545-563. PubMed ID: 34136422
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Local Tumor Progression Predictive Model Based on MRI for Colorectal Cancer Liver Metastases after Radiofrequency Ablation.
    Zhang G; Liu P; Wang G; He X; Xu L; Wang Y; Li W; Peng W
    Discov Med; 2024 Apr; 36(183):765-777. PubMed ID: 38665025
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer.
    Gao Z; Huang D; Chen H; Yang Y; An K; Ding C; Yuan Z; Zhai Z; Niu P; Gao Q; Cai J; Zeng Q; Wang Y; Hong Y; Rong W; Huang W; Lei F; Wang X; Chen S; Zhao X; Bai Y; Gu J
    J Transl Med; 2023 Jan; 21(1):63. PubMed ID: 36717891
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MRI-based radiomics approach for the prediction of recurrence-free survival in triple-negative breast cancer after breast-conserving surgery or mastectomy.
    Zhao J; Zhang Q; Liu M; Zhao X
    Medicine (Baltimore); 2023 Oct; 102(42):e35646. PubMed ID: 37861556
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preoperative factors that predict pathologic nodal involvement in early-stage HER2+ breast cancer: selecting cT1cN0 patients for treatment with neoadjuvant chemotherapy versus upfront surgery.
    Faleh S; Prakash I; Salehi A; Khan H; Basik M; Boileau JF; Tejera D; Panet F; Martel K; Meterissian S; Wong SM
    Breast Cancer Res Treat; 2024 Jun; 205(2):303-312. PubMed ID: 38381275
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Computer-aided Diagnosis-generated Kinetic Features of Breast Cancer at Preoperative MR Imaging: Association with Disease-free Survival of Patients with Primary Operable Invasive Breast Cancer.
    Kim JJ; Kim JY; Kang HJ; Shin JK; Kang T; Lee SW; Bae YT
    Radiology; 2017 Jul; 284(1):45-54. PubMed ID: 28253106
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prediction of postoperative recurrence in resectable pancreatic body/tail adenocarcinoma: a novel risk stratification approach using a CT-based nomogram.
    Xie T; Xie X; Liu W; Chen L; Liu K; Zhou Z
    Eur Radiol; 2023 Nov; 33(11):7782-7793. PubMed ID: 37624415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.